Daily Archives: October 21, 2019

FDA OKs Ustekinumab (Stelara) for Moderate to Severe UC

Ustekinumab was more effective than placebo for inducing and maintaining remission and promoting mucosal healing in a study of adults with moderately to severely active ulcerative colitis. FDA Approvals …read more

Suspect Lyme Carditis? Start Empiric Antibiotics

Waiting for test results before initiating therapy for patients suspected of having Lyme carditis may result in death, data from two recent cases show. Medscape Medical News …read more

FDA Clears First Topical Form of Minocycline for Acne

Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older. FDA Approvals …read more

Douching linked to dangerous chemicals in blood

Emerging evidence links vaginal douches with higher blood concentrations of potentially harmful chemicals, which may contribute to adverse health effects. …read more